Studies have shown that an increase in Beclin 1 expression can co-localize with caspase-3 activation [44,45], whereas the inhibition of autophagy reduces caspase-3 activation in some ischemic diseases of the CNS [44,46]. This evidence concerns the gene CASP3 and ischemic disease.